NARI (Inari) Short-Term Debt to Capital

Inari Medical, Inc. (NARI) is leveraging growing interest in minimally invasive thrombosis treatments as it plans expansion into Asia and Europe. The serial production of complex catheters is supported by line automation, which reduces the impact of human error. This price chart shows the metric at 0.00. Simultaneously, the R&D center is implementing breakthrough cardiology solutions, expanding the list of medical indications for its systems.

The investment attractiveness of Inari Medical, Inc. (NARI) is driven by the scaling of catheter production capacities, where the debt_short_eq_co ratio measures the proportion of short-term loans within the equity structure to assess liquidity. Analyzing the change in short-term liabilities relative to equity allows for a correlation between the pace of facility modernization and the debt load, confirming the fundamental stability of the business in the absence of default risk.